Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;92:423-427

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, K.W.
Right arrow Articles by Sellke, F.W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Park, K.W.
Right arrow Articles by Sellke, F.W.

(Circulation. 1995;92:423-427.)
© 1995 American Heart Association, Inc.


Articles

Isoflurane Attenuates cAMP-Mediated Vasodilation in Rat Microvessels

K.W. Park, MD; H.B. Dai, MD; E. Lowenstein, MD; A. Darvish, MS; F.W. Sellke, MD

From the Department of Anesthesia and Critical Care and the Department of Surgery, Beth Israel Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Dr Frank W. Sellke, Department of Surgery, Division of Cardiothoracic Surgery, Beth Israel Hospital, Dana 905, 330 Brookline Ave, Boston, MA 02215.

Background Endothelium-dependent vasodilation mediated by cGMP is known to be attenuated by the inhalational anesthetic isoflurane. The present study examines the effect of isoflurane on ß-adrenergic and cAMP-mediated vasodilation.

Methods and Results Fifty-three subepicardial coronary arteries (diameter, 103±13 µm) from Wistar rats were studied in vitro in a pressurized (40 mm Hg), no-flow state with use of optical density video detection system. After preconstriction of vessels with the thromboxane A2 analogue U46619 10-6 mol/L, concentration response curves to the nonselective ß-adrenergic agonist isoproterenol, the GS protein activator sodium fluoride, the adenylate cyclase activator forskolin, the cAMP analogue 8-Br-cAMP, or the phosphodiesterase inhibitor RO20-1724 were obtained either in the presence or absence (control) of 2% isoflurane. Relaxations to all the agents tested were significantly reduced in the presence of isoflurane compared with controls.

Conclusions Isoflurane attenuates cAMP-mediated vasodilation. The impairment appears to be distal to adenylate cyclase and is not due to enhancement of cAMP phosphodiesterase.


Key Words: vasodilation • receptors, adrenergic, beta • anesthesia • microcirculation